Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD01 Spray vs Comp01 Lotion in Moderate Psoriasis
NCT01947491Phase 3Completed
- Sponsor
- Primus Pharmaceuticals
- Start
- Nov 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of betamethasone dipropionate spray 0.05% in plaque psoriasis (4 arms), sponsored by Primus Pharmaceuticals. Primary endpoint: Percentage of Participants With Success According to the Investigator Global Assessment at Day 15. Started Nov 2013; status: completed.
02
Drugs
betamethasone dipropionate spray 0.05%
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01947491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01947491.